Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob, A Courboulin… - Cellular and Molecular …, 2012 - Springer
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

M Barrier, J Meloche, MH Jacob… - … and Molecular Life …, 2012 - europepmc.org
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob… - … and molecular life …, 2012 - pubmed.ncbi.nlm.nih.gov
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob, A Courboulin… - Cellular and Molecular …, 2012 - infona.pl
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

[PDF][PDF] Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob, A Courboulin… - Cell. Mol. Life …, 2012 - researchgate.net
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob… - Cell. Mol. Life …, 2012 - library-archives.canada.ca
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob… - … and Molecular Life …, 2012 - search.proquest.com
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

[HTML][HTML] Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob… - … and Molecular Life …, 2012 - ncbi.nlm.nih.gov
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension.

M Barrier, J Meloche, MH Jacob… - … and Molecular Life …, 2012 - europepmc.org
The pathobiology of pulmonary arterial hypertension (PAH) involves a remodeling process
in distal pulmonary arteries, as well as vasoconstriction and in situ thrombosis, leading to an …

[引用][C] Today's and tomorrow's imaging and circulating biomarkers for pulmonary arterial hypertension

M Barrier, J Meloche, MH Jacob, A Courboulin… - Cellular and molecular …, 2012 - Springer